These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26828132)

  • 1. Protein glycosylation in gastric and colorectal cancers: Toward cancer detection and targeted therapeutics.
    Ferreira JA; Magalhães A; Gomes J; Peixoto A; Gaiteiro C; Fernandes E; Santos LL; Reis CA
    Cancer Lett; 2017 Feb; 387():32-45. PubMed ID: 26828132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation characteristics of colorectal cancer.
    Holst S; Wuhrer M; Rombouts Y
    Adv Cancer Res; 2015; 126():203-56. PubMed ID: 25727149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal, gastric and colorectal cancers: Looking beyond classical serological biomarkers towards glycoproteomics-assisted precision oncology.
    Fernandes E; Sores J; Cotton S; Peixoto A; Ferreira D; Freitas R; Reis CA; Santos LL; Ferreira JA
    Theranostics; 2020; 10(11):4903-4928. PubMed ID: 32308758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.
    Cotton S; Azevedo R; Gaiteiro C; Ferreira D; Lima L; Peixoto A; Fernandes E; Neves M; Neves D; Amaro T; Cruz R; Tavares A; Rangel M; Silva AMN; Santos LL; Ferreira JA
    Mol Oncol; 2017 Aug; 11(8):895-912. PubMed ID: 28156048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Complexity and Dynamics of the Tissue Glycoproteome Associated With Prostate Cancer Progression.
    Kawahara R; Recuero S; Srougi M; Leite KRM; Thaysen-Andersen M; Palmisano G
    Mol Cell Proteomics; 2021; 20():100026. PubMed ID: 33127837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-glycans truncation modulates gastric cancer cell signaling and transcription leading to a more aggressive phenotype.
    Freitas D; Campos D; Gomes J; Pinto F; Macedo JA; Matos R; Mereiter S; Pinto MT; Polónia A; Gartner F; Magalhães A; Reis CA
    EBioMedicine; 2019 Feb; 40():349-362. PubMed ID: 30662000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (Sialyl)Lewis Antigen Expression on Glycosphingolipids, N-, and O-Glycans in Colorectal Cancer Cell Lines is Linked to a Colon-Like Differentiation Program.
    Wang D; Madunić K; Mayboroda OA; Lageveen-Kammeijer GSM; Wuhrer M
    Mol Cell Proteomics; 2024 Jun; 23(6):100776. PubMed ID: 38670309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid chromatography mass spectrometry-based O-glycomics to evaluate glycosylation alterations in gastric cancer.
    He Y; Xie Q; Wang Y; Liang Y; Xu X; Li Y; Miao J; Chen Z; Li Y
    Proteomics Clin Appl; 2016 Feb; 10(2):206-15. PubMed ID: 26255982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer.
    Mereiter S; Magalhães A; Adamczyk B; Jin C; Almeida A; Drici L; Ibáñez-Vea M; Gomes C; Ferreira JA; Afonso LP; Santos LL; Larsen MR; Kolarich D; Karlsson NG; Reis CA
    Biochim Biophys Acta; 2016 Aug; 1860(8):1795-808. PubMed ID: 26721331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
    Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
    J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass Spectrometry-Based N-Glycomics of Colorectal Cancer.
    Sethi MK; Fanayan S
    Int J Mol Sci; 2015 Dec; 16(12):29278-304. PubMed ID: 26690136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
    de Freitas Junior JC; Morgado-Díaz JA
    Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation Changes in Brain Cancer.
    Veillon L; Fakih C; Abou-El-Hassan H; Kobeissy F; Mechref Y
    ACS Chem Neurosci; 2018 Jan; 9(1):51-72. PubMed ID: 28982002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cell adhesion molecule CD44 and sialyl Lewis A in gastric carcinoma and colorectal carcinoma in association with hepatic metastasis.
    Isozaki H; Ohyama T; Mabuchi H
    Int J Oncol; 1998 Nov; 13(5):935-42. PubMed ID: 9772282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-glycan recognition and function in mice and human cancers.
    Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
    Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycosylation: a hallmark of cancer?
    Vajaria BN; Patel PS
    Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein glycosylation in viral hepatitis-related HCC: Characterization of heterogeneity, biological roles, and clinical implications.
    Zhang S; Cao X; Gao Q; Liu Y
    Cancer Lett; 2017 Oct; 406():64-70. PubMed ID: 28789967
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Pirro M; Mohammed Y; van Vliet SJ; Rombouts Y; Sciacca A; de Ru AH; Janssen GMC; Tjokrodirijo RTN; Wuhrer M; van Veelen PA; Hensbergen PJ
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry and pathological importance of mucin-associated antigens in gastrointestinal neoplasia.
    Baldus SE; Hanisch FG
    Adv Cancer Res; 2000; 79():201-48. PubMed ID: 10818682
    [No Abstract]   [Full Text] [Related]  

  • 20. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives.
    Chia J; Goh G; Bard F
    Biochim Biophys Acta; 2016 Aug; 1860(8):1623-39. PubMed ID: 26968459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.